About
Edison Scientific, founded in 2024 in San Francisco, USA, uses AI to help biologists and chemists read papers faster, analyze data, and design experiments.
Technology & BusinessWhat · How · Which stage
Research Areas数学与计算机科学AI基础MediumEvidence
用AI帮助生物学家与化学家更快读论文、分析数据与设计实验
Source：Official site · Updated 2026-09-10 · View source
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Funding history
- 2025-12Seed$70M
Investors · Spark Capital, Triatomic Capital, Pillar VC, Susa VenturesSource · SVTR Weekly #136 ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Edison Scientific
AI that helps biologists and chemists read papers, analyze data and design experiments faster
Seed · $70M · 2025-12
$70M
United States
BusinessLatest roundTotal raisedDate- EvolutionaryScale
Builds artificial intelligence tools that help scientists understand and design new proteins.
Seed · $182M · 2024-06
$182M - Lila Sciences
Uses AI to analyze data, design experiments and direct robotic systems to carry out experiments in the life sciences, chemistry and materials science
Series A · $550M · 2025-10
$550M - Viome
AI analysis and assessment of customers' microbiome data
Series C · $87M · 2023-08
$87M
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- Cradle
AI that helps scientists design and engineer proteins faster and more cost-effectively
Undisclosed · $106M · 2024-12
$106M - Deciphex
Digital pathology software using AI to help pathologists analyze medical samples more efficiently
Series C · $32M · 2025-01
$32M - Basecamp Research
Trains the EDEN foundation model on proprietary biodiversity genomic data and uses AI to design proteins and in vivo cell therapies
Series C · $200M · 2026-09
$200M
Other / unspecified
BusinessLatest roundTotal raisedDate- Reliant AI
Uses generative AI to help biopharma companies organize and analyze data for clinical trials or scientific publications
Seed · $11M · 2024-08
$11M - BenchSci
Equips scientists with advanced biomedical AI technology
Undisclosed · $70M · 2023-05
$70M - Harrison.ai
Develops AI tools to help physicians interpret medical images such as X-rays, CT scans and pathology slides more quickly and accurately
Series C · $112M · 2025-05
$112M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
39 Life Sciences deals in the last 24 months · 18 at a nearby stage · 35 in Silicon Valley
Request intro →Y Combinator
38 Life Sciences deals in the last 24 months · 26 at a nearby stage · 31 in Silicon Valley
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 11 at a nearby stage · 22 in Silicon Valley
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 7 at a nearby stage · 20 in Silicon Valley
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 3 at a nearby stage · 15 in Silicon Valley
Request intro →Lightspeed
16 Life Sciences deals in the last 24 months · 5 at a nearby stage · 14 in Silicon Valley
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.